Literature DB >> 11161607

Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP.

O A Andreassen1, R J Ferrante, A Dedeoglu, D W Albers, P Klivenyi, E J Carlson, C J Epstein, M F Beal.   

Abstract

There is substantial evidence implicating mitochondrial dysfunction and free radical generation as major mechanisms of neuronal death in neurodegenerative diseases. The major free radical scavenging enzyme in mitochondria is manganese superoxide dismutase (SOD2). In the present study we investigated the susceptibility of mice with a partial deficiency of SOD2 to the neurotoxins 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP), 3-nitropropionic acid (3-NP), and malonate, which are commonly used animal models of Parkinson's and Huntington's disease. Heterozygous SOD2 knockout (SOD2(+/-)) mice showed no evidence of neuropathological or behavioral abnormalities at 2-4 months of age. Compared to littermate wild-type mice, mice with partial SOD2 deficiency showed increased vulnerability to dopamine depletion after systemic MPTP treatment and significantly larger striatal lesions produced by both 3-NP and malonate. SOD2(+/-) mice also showed an increased production of "hydroxyl" radicals after malonate injection measured with the salicylate hydroxyl radical trapping method. These results provide further evidence that reactive oxygen species play an important role in the neurotoxicity of MPTP, malonate, and 3-NP. These findings show that a subclinical deficiency in a free radical scavenging enzyme may act in concert with environmental toxins to produce selective neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161607     DOI: 10.1006/exnr.2000.7525

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  31 in total

Review 1.  On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Dennis P Riley; Jay L Zweier; Christoph Thiemermann; Zhi-Qiang Wang; Daniela Salvemini
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

2.  Oxygen toxicity and the health and survival of eukaryote cells: a new piece is added to the puzzle.

Authors:  F Archibald
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-25       Impact factor: 11.205

Review 3.  MPTP as a mitochondrial neurotoxic model of Parkinson's disease.

Authors:  Serge Przedborski; Kim Tieu; Celine Perier; Miquel Vila
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

4.  Mitochondrial SIRT3 Mediates Adaptive Responses of Neurons to Exercise and Metabolic and Excitatory Challenges.

Authors:  Aiwu Cheng; Ying Yang; Ye Zhou; Chinmoyee Maharana; Daoyuan Lu; Wei Peng; Yong Liu; Ruiqian Wan; Krisztina Marosi; Magdalena Misiak; Vilhelm A Bohr; Mark P Mattson
Journal:  Cell Metab       Date:  2015-11-19       Impact factor: 27.287

5.  Calcium dysregulation mediates mitochondrial and neurite outgrowth abnormalities in SOD2 deficient embryonic cerebral cortical neurons.

Authors:  Qijin Zhao; Daoyuan Lu; Jing Wang; Beibei Liu; Heping Cheng; Mark P Mattson; Aiwu Cheng
Journal:  Cell Death Differ       Date:  2018-11-02       Impact factor: 15.828

6.  Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's disease.

Authors:  Li-Ping Liang; Jie Huang; Ruth Fulton; Jennifer N Pearson-Smith; Brian J Day; Manisha Patel
Journal:  Toxicol Appl Pharmacol       Date:  2017-04-08       Impact factor: 4.219

Review 7.  Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease.

Authors:  Derek A Drechsel; Manisha Patel
Journal:  Free Radic Biol Med       Date:  2008-03-04       Impact factor: 7.376

8.  Localization of superoxide anion production to mitochondrial electron transport chain in 3-NPA-treated cells.

Authors:  Attila Bacsi; Mitchell Woodberry; William Widger; John Papaconstantinou; Sankar Mitra; Johnny W Peterson; Istvan Boldogh
Journal:  Mitochondrion       Date:  2006-08-03       Impact factor: 4.160

9.  Neuroprotection by transgenic expression of glucose-6-phosphate dehydrogenase in dopaminergic nigrostriatal neurons of mice.

Authors:  Rebeca Mejías; Javier Villadiego; C Oscar Pintado; Pablo J Vime; Lin Gao; Juan J Toledo-Aral; Miriam Echevarría; José López-Barneo
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

10.  Chelation of mitochondrial iron prevents seizure-induced mitochondrial dysfunction and neuronal injury.

Authors:  Li-Ping Liang; Stuart G Jarrett; Manisha Patel
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.